REICH KRISTIAN (Chief Scientific Officer) sold 0.6% of their position (16.11K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $322.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2026ACC: 0001213900-26-079376
Officer· Chief Scientific Officer
Since Apr 2022
-16.11K
Net shares
Net seller
$322.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.11K disposed
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Indirect
Shares
−16.11K
Price / share
$20.01
Trade value
$322.26K
% of position
0.6%
7/15/2026
2.82M→2.81M
Total
Net shares
−16.11K
Net value
-$322.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Indirect | 7/15/2026 | S · Sale | −16.11K | $20.01 | $322.26K | 0.6% | 2.82M | 2.81M |
| Total | −16.11K | -$322.26K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A ordinary shares, par value $0.0001 per share
DirectShares owned35.39K
Total
35.39K direct35.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A ordinary shares, par value $0.0001 per share | 35.39K | Direct |
| Total | 35.39K | 35.39K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported